VEGFA and Anxiety: Women were found to have, on average, 10.8 mm more of anxiety levels than men (p=0.03), and patients treated with aflibercept had, on average, 14.6 mm less of anxiety levels compared to those treated with other anti-VEGF (p=0.046).